Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation

Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation

Introduction. Mucinous adenocarcinoma of the prostate is a rare variant of prostate cancer. Its malignant potential and the clinical course of the affected patients remain, by and large, controversial. No data exist about the course of metastatic mucinous adenocarcinoma of the prostate. Case Presen...

Full description

Bibliographic Details
Main Authors:	Christos Kalaitzis, Michael Koukourakis, Stilianos Giannakopoulos, Alexandra Giatromanolaki, Efthimios Sivridis, Athanasios Bantis, Stavros Touloupidis
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Case Reports in Urology
Online Access:	http://dx.doi.org/10.1155/2014/218628

Similar Items

Osteolytic bone destruction resulting from relapse of a testicular tumour 23 years after inguinal orchiectomy and adjuvant chemotherapy: a case report
by: Kalaitzis Christos, et al.
Published: (2009-07-01)

A Case Report of Urinary Bladder Carcinosarcoma and Review of the Literature
by: Christos Zachariadis, et al.
Published: (2011-01-01)

Ureteroscopic Laser Treatment of Upper Urinary Tract Urothelial Cell Carcinomas: Can a Tumour Free Status Be Achieved?
by: Christos Kalaitzis, et al.
Published: (2013-01-01)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
by: Alexander I. Hinev, et al.
Published: (2012-01-01)

Laparoscopic Transvesical Resection of an En Bloc Bladder Cuff and Distal Ureter during Nephroureterectomy
by: Stilianos Giannakopoulos, et al.
Published: (2012-01-01)

Free PSA estimation substituted by calculation where total PSA value is up to 4 ng/ml
by: M Dhumne, et al.
Published: (2006-01-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)

Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL
by: Katia R. Leite, et al.
Published: (2008-06-01)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
by: Patrick Temi Adegun, et al.
Published: (2015-07-01)

Comparison of Pathology and Prevalence of Prostate Cancer in Patients with PSA between 4-10 ng/ml
by: A Tabibi, et al.
Published: (2008-01-01)

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
by: Emerson P. Gregorio, et al.
Published: (2007-04-01)

Perforation of the Urinary Bladder Caused by Transurethral Insertion of a Pencil for the Purpose of Masturbation in a 29-Year-Old Female
by: Athanasios Bantis, et al.
Published: (2010-01-01)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml -1 and 10.1-20.0 ng ml -1 : a multicenter study
by: Yu-Rong Lin, et al.
Published: (2015-06-01)

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report
by: Michael H. Johnson, et al.
Published: (2015-09-01)

The Chances of Subsequent Cancer Detection in Patients with a PSA > 20 ng/ml and an Initial Negative Biopsy
by: Nadeem Shaida, et al.
Published: (2009-01-01)

Decision Tree Analysis for Prostate Cancer Prediction in Patients with Serum PSA 10 ng/ml or Less
by: Pantic Damjan N, et al.
Published: (2020-03-01)

Outcome of laparoscopic radical prostatectomy with intended wide resection in prostate cancer patients with a preoperative serum PSA level > 50 ng/ml: A single surgeon experience
by: Yen-Hsi Lee, et al.
Published: (2016-06-01)

Laparoscopic transvesical vesicovaginal fistula repair with the least invasive way: Only three trocars and a limited posterior cystotomy
by: Stilianos Giannakopoulos, et al.
Published: (2020-10-01)

Correlation of Serum Androgens and Pituitary Hormone Levels with Serum PSA Less Than 2.5 NG/ML
by: Mustafa Sofikerim, et al.
Published: (2007-01-01)

Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml
by: Niraj Kumar, et al.
Published: (2019-01-01)

Angiogenic Factor Expression in Hepatic Cirrhosis
by: Efthimios Sivridis, et al.
Published: (2007-01-01)

Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1
by: Cheng Wang, et al.
Published: (2021-01-01)

Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL?
by: W. F. S. Busato, et al.
Published: (2015-04-01)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
by: Xin LIU, et al.
Published: (2015-11-01)

Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA range
by: I. Vukovic, et al.

Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
by: Yuanyuan Guo, et al.
Published: (2018-11-01)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml.
by: Rui Chen, et al.
Published: (2015-01-01)

Frequência de Adenocarcinoma Prostático em biópsias de 12 ou 18 fragmentos de pacientes com valores de PSA total entre 2,5 e 10 ng/ml, relação PSAlivre / PSAtotal ≤ 19% e densidade do PSA ≥ 15ng/ml/cc
by: Souza, Paulo José Gonçalves de
Published: (2017)

Radiological findings and the clinical importance of megacalycosis
by: Kalaitzis C, et al.
Published: (2015-10-01)

The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL
by: Cem Yücel, et al.
Published: (2018-06-01)

Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4–10 ng/mL
by: Yongqiang Zhou, et al.
Published: (2017-01-01)

PSA levels of 4.0 - 10 ng/ml and negative digital rectal examination: antibiotic therapy versus immediate prostate biopsy
by: Avraham Shtricker, et al.
Published: (2009-10-01)

Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/ml undergoing radical cystoprostatectomy for bladder cancer in iranian men
by: S.Y. Hosseini, et al.
Published: (2007-04-01)

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1
by: Lincoln GL Tan, et al.
Published: (2017-01-01)

Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL
by: Hugo A. Socrates Castro, et al.

Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: a population-based study
by: Zhibo Zheng, et al.
Published: (2020-04-01)

Predictive factors of prostate cancer diagnosis with PSA 4.0–10.0 ng/ml in a multi-ethnic Asian population, Malaysia
by: Raymond Shi Liang Yii, et al.
Published: (2020-01-01)

Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4–10 ng/mL
by: Po-Fan Hsieh, et al.
Published: (2018-08-01)

Contribuição da densidade do PSA para predizer o câncer da próstata em pacientes com valores de PSA entre 2,6 e 10,0 ng/ml
by: Hugo Alexandre Sócrates de Castro, et al.
Published: (2011-08-01)

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
by: Umezawa Rei, et al.
Published: (2011-11-01)